Review
Cell Biology
Tomasz Klaus, Sameer Deshmukh
Summary: pH-responsive antibodies show strong treatment potential as programmable engineered biologic drugs, targeting the acidified tumor microenvironment with improved spatial persistence and reduced toxicities. They can also be used in CAR-T engineering and improving drug delivery to the brain.
JOURNAL OF BIOMEDICAL SCIENCE
(2021)
Review
Neurosciences
Gabriele Deidda, Manuele Biazzo
Summary: The physiological and pathological functions of the brain depend on both neuronal and non-neuronal populations. The gut brain, formed by microbial populations living in the gut, communicates with the human brain via the gut-brain axis and has an influence on brain functions, potentially becoming a therapeutic target for brain pathologies.
FRONTIERS IN NEUROSCIENCE
(2021)
Review
Nutrition & Dietetics
Yadong Zheng, Laura Bonfili, Tao Wei, Anna Maria Eleuteri
Summary: The gut-brain axis is a complex communication network between the gut and brain, involving neural, immune, and endocrine pathways. The gut microbiota plays an important role in this axis and its dysbiosis has been associated with neurodegenerative disorders. Manipulating the gut microbiota shows promise as a potential therapeutic target for these diseases.
Article
Neurosciences
Chongyun Wu, Peibin Zou, Shu Feng, Ling Zhu, Fanghui Li, Timon Cheng-Yi Liu, Rui Duan, Luodan Yang
Summary: Oxidative stress and neuroinflammation play important roles in the development of neurodegenerative disorders and brain injuries. Molecular hydrogen has demonstrated excellent antioxidant and anti-inflammatory effects, making it a promising therapy for various brain disorders. This paper reviews the administration routes, effects, and underlying mechanisms of hydrogen therapy in brain disorders, while also discussing the remaining challenges in its implementation.
MOLECULAR NEUROBIOLOGY
(2023)
Review
Chemistry, Multidisciplinary
Grace Tsz Yan Yau, Waiting Tai, Jonathon Carl Arnold, Hak-Kim Chan, Philip Chi Lip Kwok
Summary: The use of cannabidiol (CBD) for treating brain disorders has gained increasing interest. This review examines the preclinical and clinical evidence on the therapeutic use of CBD in treating various brain disorders, as well as different drug delivery approaches for CBD.
PHARMACEUTICAL RESEARCH
(2023)
Review
Cell Biology
Hongzhen Chen, Dewei Shang, Yuguan Wen, Chao Liang
Summary: Traditionally viewed as a structural organ, bone is now recognized as an endocrine organ that regulates metabolism and brain development. Abnormal bone metabolism is linked to neurological disorders. Various bone-derived modulators and bone marrow-derived cells play roles in brain function and neurological disorders.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Review
Biochemistry & Molecular Biology
Ipek Akol, Fabian Gather, Tanja Vogel
Summary: FOXG1 plays a crucial role in CNS development and its mutations lead to FOXG1 syndrome. Understanding FOXG1 syndrome can contribute to the development of therapeutic interventions and clinical interventions.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Medicine, General & Internal
Prabhakar Tiwari, Rekha Dwivedi, Manisha Bansal, Manjari Tripathi, Rima Dada
Summary: The gut microbiota (GM) plays a significant role in human metabolism, immune system, and neurological disorders. It interacts with the gastrointestinal tract and contributes to the gut-brain axis (GBA) through bidirectional transmission. The GM can be regulated and supplemented with prebiotics, probiotics, postbiotics, synbiotics, fecal transplantations, and antibiotics to treat neurological disorders.
JOURNAL OF CLINICAL MEDICINE
(2023)
Review
Chemistry, Multidisciplinary
Elisa Panzarini, Stefania Mariano, Stefano Tacconi, Elisabetta Carata, Ada Maria Tata, Luciana Dini
Summary: Nutraceuticals serve as beneficial supplements to modern medicine, with curcumin being an attractive herbal compound due to its multipurpose properties. However, its instability and susceptibility to degradation pose limits to its clinical development, particularly in the context of brain pathologies involving the blood brain barrier. Various studies have focused on developing nanoconstructs to enhance the stability and bioavailability of curcumin, showing promising therapeutical potential in treating neurological disorders.
Review
Chemistry, Multidisciplinary
Adilet Beishenaliev, Yean Leng Loke, Sook Jing Goh, Hui Nee Geo, Malar Mugila, Misni Misran, Lip Yong Chung, Lik Voon Kiew, Steve Roffler, Yin Yin Teo
Summary: Monospecific antibodies have limitations in delivering drugs to tumors with multiple epitopes, while bispecific antibodies provide a promising alternative by simultaneously targeting two distinct antigens or epitopes. This review discusses the roles of bispecific antibodies in enhancing the internalization and intracellular trafficking of drug-conjugated antibodies and facilitating the delivery of drug-encapsulating nanoconstructs.
JOURNAL OF CONTROLLED RELEASE
(2023)
Review
Medicine, General & Internal
Christopher Tait, Gregory S. Sayuk
Summary: Functional gastrointestinal disorders are common diseases characterized by chronic abdominal complaints without an obvious cause. Recent research highlights the importance of the brain-gut axis in these disorders.
EUROPEAN JOURNAL OF INTERNAL MEDICINE
(2021)
Review
Pharmacology & Pharmacy
Maria Daniela Ferreira, Joana Duarte, Francisco Veiga, Ana Claudia Paiva-Santos, Patricia C. Pires
Summary: Oral administration of antipsychotic drugs is the first-line treatment for psychotic disorders. However, adverse drug reactions and patient non-compliance are major challenges. Intranasal delivery shows advantages over oral and intravenous administration, allowing direct nose-to-brain drug transport and reducing side effects. Incorporating antipsychotic drugs into nanosystems has shown promising results in improving brain bioavailability and therapeutic effects in animal models.
Review
Chemistry, Medicinal
Cecilia Pandini, Federica Rey, Cristina Cereda, Stephana Carelli, Paolo Gandellini
Summary: Long non-coding RNAs (lncRNAs) play crucial roles in pediatric neurological diseases and have implications for neural development and disorders. Further research is needed to fully understand the involvement of lncRNAs in pediatric neurological diseases and brain tumors, offering potential therapeutic targets and biomarkers.
Review
Pharmacology & Pharmacy
Dalia T. Abdeldaim, Katharina Schindowski
Summary: Fc engineering aims to enhance the effector functions, half-life, and stability of therapeutic antibodies, leading to the development of next generation antibody therapies.
Article
Neurosciences
He Chen, Yuanping Dong, Yun Wu, Feng Yi
Summary: This mini-review examines the role of N-Methyl-d-aspartate (NMDA) receptor hyperfunction in depression and neurodegenerative diseases, and NMDA receptor hypofunction in schizophrenia. It discusses both ion flux-dependent and ion flux-independent signaling of the NMDA receptor, and reviews current strategies and promising future directions for developing therapeutic agents targeting NMDA receptor signaling.
REVIEWS IN THE NEUROSCIENCES
(2023)